Breast Cancer Clinical Trial

Plan to Thrive: Extending Cancer Survivorship Care Beyond the Clinic

Summary

The purpose of this study is to test the usability of the Plan To Thrive smartphone application with cancer survivors. This study will involve three visits (baseline, follow-up, and feedback assessments). Between the baseline and follow-up time points, patients will undergo a 90-day period in which they will engage with app content. It is hypothesized that cancer survivors in this study will find the smartphone application, Plan to Thrive, an acceptable and feasible way to access post-treatment information. In addition, the investigators will explore preliminary efficacy by examining changes over time in primary (patient activation, patient knowledge and adherence to follow-up care recommendations and health behaviors) and secondary outcomes [symptom burden, health-related quality of life and patient satisfaction].

View Eligibility Criteria

Eligibility Criteria

INCLUSION CRITERIA:

At least 18 years of age or older
Prior history of cancer
Completion of primary cancer treatment (i.e., surgery, chemotherapy and/or radiation; but can be receiving hormonal treatment)
Have an e-mail account and reliable broadband access to the Internet
Able to read, understand, and speak English sufficiently to understand study questionnaires and consent form

EXCLUSION CRITERIA:

Has a medical condition with a life expectancy of fewer than 12 months
Physical or cognitive disability that would prohibit them from participating in study procedures
Having prior inpatient psychiatric treatment, or overt signs of, severe psychopathology (e.g., psychosis, substance dependence, suicidality)

Study is for people with:

Breast Cancer

Estimated Enrollment:

33

Study ID:

NCT03996031

Recruitment Status:

Completed

Sponsor:

Northwestern University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Robert H. Lurie Comprehensive Cancer Center
Chicago Illinois, 60611, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

33

Study ID:

NCT03996031

Recruitment Status:

Completed

Sponsor:


Northwestern University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider